Telangana: Natco Pharma has announced the superannuation of Dr Ramesh Dandala, Executive Vice President - Technology Transfer ...

Other names on the Nifty Pharma index that has a significant upside potential include Aurobindo Pharma and Ajanta Pharma, both of which have an upside potential of 23%.

Natco Pharma has announced the supperannuation of Tummala Venkata Rao, Vice President - Production of the Company."With ...

Indian pharma stocks surge as generic drugmakers exempted from U.S. tariff, boosting Nifty Pharma shares and industry outlook ...

The Delhi High Court denied Roche's request to temporarily restrain Natco Pharma from producing its spinal muscular atrophy ...

Indian pharmaceutical industry welcomes U.S. tariff exemption, boosting stock prices and reinforcing commitment to affordable, quality medicines.

Shares of Indian pharmaceutical firms rose 3%-13% after Trump did not specify reciprocal tariffs for the sector. The ...

Roche had appealed against a single judge order of March 24 that had refused to stop Natco Pharma from manufacturing a generic version of Risdiplam ...

Patients with Spinal Muscular Atrophy (SMA) are hopeful of getting access to generic versions of Roche’s patented drug ...

Currently, US charges nearly zero duty on pharmaceutical imports, while India imposes around 10 percent tax on pharma imports ...

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA ...

Indian Pharma stocks in focus on Trump tariffs exemption, Nifty Pharma and healthcare indices end in green. Ipca Laboratories, Lupin, Natco Pharma, Sun Pharma and Cipla lead rally.